Tolerability, pharmacokinetics and pharmacodynamics of ascending single and repeated doses of SAR444336 in healthy adult participants

Trial Identifier: TDR17161
Sponsor: Sanofi
Start Date: October 2022
Study Completion Date: December 2023
Condition: IBD; Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

No locations posted.